Market Research

Respiratory Filters Market Size, Share & Trends Analysis Report By Product (Nebulizer Filters, Humidifier Filters, Ventilator Filters), By End-use (Hospitals, Outpatient Facilities, Home Care), By Region, And Segment Forecasts, 2023 - 2030

Best Price Guarantee Length Publisher Published Date SKU
from $5,950 120 Pages Grand View Research September, 2023 GV18259503
Best Price Guarantee
Price from $5,950
Length 120 Pages
Publisher Grand View Research
Published Date September, 2023
SKU GV18259503

Respiratory Filters Market Size, Share & Trends Analysis Report By Product (Nebulizer Filters, Humidifier Filters, Ventilator Filters), By End-use (Hospitals, Outpatient Facilities, Home Care), By Region, And Segment Forecasts, 2023 - 2030


Respiratory Filters Market Growth & Trends


The global respiratory filters market size is expected to reach USD 802.4 million by 2030, registering a CAGR of 5.5% from 2023 to 2030, according to a new study by Grand View Research, Inc. Growth in the market is driven by the increasing prevalence of chronic respiratory diseases, strategic initiatives by organizations, technological advancements, and the cost-effectiveness of the devices. Moreover, the increased awareness about respiratory health and the importance of preparedness for future respiratory emergencies have highlighted the need for improved respiratory support infrastructure. As a result, governments and healthcare institutions may invest in upgrading and expanding their respiratory device capabilities, thus holding potential growth for the market.

According to the CDC, the incidence of Tuberculosis (TB) (cases per 100,000 population) among Americans increased from 0.71 in 2020 to 0.79 in 2021, while it grew from 11.71 in 2020 to 12.16 in 2021 among non-Americans. Growing number of patients with TB further increases the demand for respiratory care devices used in TB therapy. For instance, during and after TB treatment, respirators, nebulizers, polysomnography devices, BiPAP devices, etc., are frequently utilized, which, in turn, is boosting the demand for respiratory care devices, including respiratory filters. The COVID-19 pandemic has been advantageous for the overall market, and it has had a positive impact on its growth. The demand for some key products, such as ventilators, Continuous Positive Airway Pressure (CPAP) machines, and oxygen concentrators increased by 4-5 times, thereby driving market growth. While the pandemic drove the initial surge in demand, the long-term market outlook for respiratory filters remains positive.

Respiratory Filters Market Report Highlights

  • The overall market growth is attributed to the increasing prevalence of respiratory diseases, such as asthma and COPD, and the rising global geriatric population
  • The positive airway pressure device filters segment accounted for the largest revenue share of 23.9% in 2022. The growing patient pool suffering from obstructive sleep apnea is expected to drive the demand for PAP devices
  • The hospitals end-use segment dominated the market with a revenue share of 33.93% in 2022 and is expected to continue its dominance with the fastest CAGR of 5.9% over the forecast period
  • North America dominated the market and accounted for the largest share of 37.2% in 2022 due to the continuous product launches and availability of the latest technologies
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of respiratory diseases
3.2.1.2. Growing global geriatric population
3.2.1.3. Supportive initiatives by government and private organizations
3.2.2. Market Restraint Analysis
3.2.2.1. Product recall & failure
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Respiratory Filters Market: Product Movement Analysis
4.2. Nebulizer Filters
4.2.1. Nebulizer Filters Market, 2018 - 2030 (USD Million)
4.2.1.1. Inlet Filter
4.2.1.2. Replacement Filter
4.2.1.3. Cabinet Filter
4.3. Humidifiers Filters
4.3.1. Humidifiers Filters Market, 2018 - 2030 (USD Million)
4.3.1.1. Wick Filter
4.3.1.2. Permanent Cleanable Filter
4.3.1.3. Mineral Absorption Pads
4.3.1.4. Demineralization Cartridges
4.4. Positive airway pressure device filters
4.4.1. Positive Airway Pressure Device Filters Market, 2018 - 2030 (USD Million)
4.4.1.1. Ultra-fine Foam Inlet Filter
4.4.1.2. Polyester Non-woven Fiber Filter
4.4.1.3. Acrylic & Polypropylene Fiber Filter
4.5. Oxygen Concentrators Filters
4.5.1. Oxygen Concentrators Filters Market, 2018 - 2030 (USD Million)
4.5.1.1. HEPA Filter
4.5.1.2. Cabinet Filter
4.5.1.3. Pre-Inlet Filter
4.5.1.4. Inlet Filter
4.5.1.5. Micro Disk Filter
4.5.1.6. Felt Intake Filter
4.5.1.7. Bacterial Filter
4.5.1.8. Hollow-Membrane Filter
4.6. Ventilator Filters
4.6.1. Ventilator Filters Market, 2018 - 2030 (USD Million)
4.6.1.1. Mechanical Filters
4.6.1.2. Electrostatic Filters
Chapter 5. End-use Business Analysis
5.1. Respiratory Filters Market: End-use Movement Analysis
5.2. Hospitals
5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
5.3. Outpatient Facilities
5.3.1. Outpatient Facilities Market, 2018 - 2030 (USD Million)
5.4. Home Care
5.4.1. Home Care Companies Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Respiratory Filters Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Respiratory Filters Market, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. U.S. Respiratory Filters Market, 2018 - 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Canada Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Target Disease Prevalence
6.3.2.3. Competitive Scenario
6.3.2.4. Regulatory Framework
6.3.2.5. UK Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. Germany Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. France Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. Italy Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Spain Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Denmark Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Sweden Respiratory Filters Market, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Norway Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Competitive Scenario
6.4.2.4. Regulatory Framework
6.4.2.5. Japan Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. China Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. India Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. Australia Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Thailand Respiratory Filters Market, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. South Korea Respiratory Filters Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Respiratory Filters Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Competitive Scenario
6.5.2.4. Regulatory Framework
6.5.2.5. Brazil Respiratory Filters Market, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Mexico Respiratory Filters Market, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Argentina Respiratory Filters Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Respiratory Filters Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Competitive Scenario
6.6.2.4. Regulatory Framework
6.6.2.5. South Africa Respiratory Filters Market, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. Saudi Arabia Respiratory Filters Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. UAE Respiratory Filters Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. Kuwait Respiratory Filters Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Categorization
7.1.1. GE Healthcare
7.1.1.1. Overview
7.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Koninklijke Philips N.V.
7.1.2.1. Overview
7.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. ICU Medical (Smiths Medical)
7.1.3.1. Overview
7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Invacare Corporation
7.1.4.1. Overview
7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Medtronic
7.1.5.1. Overview
7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Fisher & Paykel Healthcare
7.1.6.1. Overview
7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. ResMed
7.1.7.1. Overview
7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. CAIRE Inc. (NGK SPARK PLUG CO., LTD.)
7.1.8.1. Overview
7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Ltd Linde
7.1.9.1. Overview
7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Mindray
7.1.10.1. Overview
7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Chart Industries
7.1.11.1. Overview
7.1.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
7.1.12. Drägerwerk AG & Co. KGaA
7.1.12.1. Overview
7.1.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.12.3. Product Benchmarking
7.1.12.4. Strategic Initiatives
7.1.13. DeVilbiss Healthcare
7.1.13.1. Overview
7.1.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.1.13.3. Product Benchmarking
7.1.13.4. Strategic Initiatives
7.2. Participant’s Overview
7.3. Financial Performance
7.4. Product Benchmarking
7.5. Company Market Share Analysis, 2022
7.6. Strategy Mapping
7.6.1. Expansion
7.6.2. Acquisition
7.6.3. Product/Service Launch
7.6.4. Others

$5,950
$6,950
$8,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings